Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...

Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on ...

Eli Lilly and Novo Nordisk are currently the only drugmakers with FDA approved weight-loss medicines on the U.S. market.

Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 ...

Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...

With the sales of weight-loss drugs booming, India is now the epicentre of the global obesity treatment market, reports The ...

From supplements to injectables to belly-fat blasting beverages, there are plenty of products that claim to speed weight loss ...